Immunotherapy of Advanced Cancer

Charles G. Moertel; Richard Nora; Chandra Belani; Henry Silverman; Jeffrey Abrams; William H. West; Kurt W. Tauer; Robert K. Oldham; Douglas W. Orr; John Yannelli; Elizabeth Ann Grimm; Steven A. Rosenberg

doi:10.1056/NEJM198701293160513

Immunotherapy of Advanced Cancer

Charles G. Moertel
, Richard Nora
, Chandra Belani
, Henry Silverman
, Jeffrey Abrams
, William H. West
, Kurt W. Tauer
, Robert K. Oldham
, Douglas W. Orr
, John Yannelli
, Elizabeth Ann Grimm
, Steven A. Rosenberg

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Abstract

To the Editor: The report of Rosenberg and associates (Dec. 5, 1985, issue)¹ describing their experience with adoptive immunotherapy of advanced cancer is certainly of scientific interest. The presentation of this study by the public media, however, has generated unrealistic expectations among patients with advanced cancer and their families, as evidenced by the thousands of calls pouring in to physicians and cancer centers. Out of concern for these patients, I hope that the investigators will join me in the following realistic appraisal of their results. (1) There is no evidence that this therapy will cure human cancer. (2) There is…

Original language	English (US)
Pages (from-to)	274-276
Number of pages	3
Journal	New England Journal of Medicine
Volume	316
Issue number	5
DOIs	https://doi.org/10.1056/NEJM198701293160513
State	Published - Jan 29 1987

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1056/NEJM198701293160513

Cite this

@article{23b41d75e54f4d2c9ae8f0fbeeb81b22,

title = "Immunotherapy of Advanced Cancer",

abstract = "To the Editor: The report of Rosenberg and associates (Dec. 5, 1985, issue)1 describing their experience with adoptive immunotherapy of advanced cancer is certainly of scientific interest. The presentation of this study by the public media, however, has generated unrealistic expectations among patients with advanced cancer and their families, as evidenced by the thousands of calls pouring in to physicians and cancer centers. Out of concern for these patients, I hope that the investigators will join me in the following realistic appraisal of their results. (1) There is no evidence that this therapy will cure human cancer. (2) There is…",

author = "Moertel, \{Charles G.\} and Richard Nora and Chandra Belani and Henry Silverman and Jeffrey Abrams and West, \{William H.\} and Tauer, \{Kurt W.\} and Oldham, \{Robert K.\} and Orr, \{Douglas W.\} and John Yannelli and Grimm, \{Elizabeth Ann\} and Rosenberg, \{Steven A.\}",

year = "1987",

month = jan,

day = "29",

doi = "10.1056/NEJM198701293160513",

language = "English (US)",

volume = "316",

pages = "274--276",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "5",

}

TY - JOUR

T1 - Immunotherapy of Advanced Cancer

AU - Moertel, Charles G.

AU - Nora, Richard

AU - Belani, Chandra

AU - Silverman, Henry

AU - Abrams, Jeffrey

AU - West, William H.

AU - Tauer, Kurt W.

AU - Oldham, Robert K.

AU - Orr, Douglas W.

AU - Yannelli, John

AU - Grimm, Elizabeth Ann

AU - Rosenberg, Steven A.

PY - 1987/1/29

Y1 - 1987/1/29

N2 - To the Editor: The report of Rosenberg and associates (Dec. 5, 1985, issue)1 describing their experience with adoptive immunotherapy of advanced cancer is certainly of scientific interest. The presentation of this study by the public media, however, has generated unrealistic expectations among patients with advanced cancer and their families, as evidenced by the thousands of calls pouring in to physicians and cancer centers. Out of concern for these patients, I hope that the investigators will join me in the following realistic appraisal of their results. (1) There is no evidence that this therapy will cure human cancer. (2) There is…

AB - To the Editor: The report of Rosenberg and associates (Dec. 5, 1985, issue)1 describing their experience with adoptive immunotherapy of advanced cancer is certainly of scientific interest. The presentation of this study by the public media, however, has generated unrealistic expectations among patients with advanced cancer and their families, as evidenced by the thousands of calls pouring in to physicians and cancer centers. Out of concern for these patients, I hope that the investigators will join me in the following realistic appraisal of their results. (1) There is no evidence that this therapy will cure human cancer. (2) There is…

UR - https://www.scopus.com/pages/publications/0023090575

UR - https://www.scopus.com/pages/publications/0023090575#tab=citedBy

U2 - 10.1056/NEJM198701293160513

DO - 10.1056/NEJM198701293160513

M3 - Letter

C2 - 3491962

AN - SCOPUS:0023090575

SN - 0028-4793

VL - 316

SP - 274

EP - 276

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 5

ER -

Immunotherapy of Advanced Cancer

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this